Investment Rating - The report maintains an "Overweight" rating for the biomedical sector [4] Core Insights - The brain-computer interface (BCI) industry is at a critical stage of policy support, rapid technological iteration, and accelerated commercialization, with a global market approaching $10 billion [3][9] - The industry is driven by both policy and technology, with significant investments from major countries, including approximately $4.5 billion from the U.S. BRAIN Initiative and hundreds of billions in China [1][51] - The medical application of BCI technology is the most mature segment, focusing on neurorehabilitation, functional replacement, and disease treatment, with a dual growth curve emerging from medical and consumer applications [2][45] Summary by Sections Industry Overview - BCI is defined as a technology that creates a communication channel between the brain and external devices, enabling direct information exchange [16] - BCI can be categorized into invasive, semi-invasive, and non-invasive types, each with distinct applications in medical rehabilitation, consumer interaction, and military use [17][19] - The global BCI market is projected to grow from $1.2 billion in 2019 to approximately $7.63 billion by 2029, with a compound annual growth rate (CAGR) exceeding 13% [24] Policy Guidance - Major countries have launched BCI-related initiatives, with the U.S. and EU leading in funding and research efforts [52][53] - China's "Brain Plan" aims to enhance brain science and BCI technology, with significant funding expected in the coming years [54][57] Clinical Applications - The medical sector is the primary focus for BCI applications, with significant demand driven by conditions such as stroke and disabilities [45][48] - Clinical trials for BCI products are accelerating globally, with notable advancements in both invasive and non-invasive technologies [3][19] Industry Progress - The report highlights the competitive landscape, noting that while foreign companies like Neuralink and Synchron have a head start, domestic firms are making significant strides in key areas such as flexible electrodes and real-time language decoding [2][4][30] - The BCI industry is characterized by a complex supply chain, with upstream components like electrodes and chips, midstream product supply, and downstream applications across various sectors [30][33] Investment Recommendations - Investors are advised to focus on companies with strong technological barriers and clinical application capabilities, particularly in the medical sector, which is the most developed area for BCI commercialization [3][9] - Specific companies to watch include medical scene integrators and leaders in invasive/semi-invasive technologies, such as Xiangyu Medical, Weisi Medical, and Brain Tiger Technology [3][9]

Core Viewpoint - The brain-computer interface (BCI) industry is transitioning from a fragmented approach to a coordinated national strategy, aiming for sustainable development and innovation in the sector [1][3]. Group 1: Policy and Strategic Goals - The Ministry of Industry and Information Technology and other departments have issued an implementation opinion to promote the innovation and development of the BCI industry, outlining five key tasks and 17 specific measures [1][2]. - By 2027, breakthroughs in key BCI technologies are expected, with the establishment of advanced technical, industrial, and standard systems, and products reaching international standards [1][2]. - By 2030, the BCI industry aims to cultivate 2 to 3 globally influential leading enterprises and a number of specialized small and medium-sized enterprises, enhancing its international competitiveness [1]. Group 2: Industry Development and Application - The BCI industry is entering a new historical development phase, with a focus on accelerating the application of technology and innovation [3][4]. - The implementation opinion emphasizes the importance of enhancing basic hardware and software capabilities, promoting the application of technological achievements, and improving product interoperability and usability [3][4]. - Companies are expected to increase R&D investments in critical areas such as biocompatible materials and minimally invasive implantation techniques [5][6]. Group 3: Funding and Support - The implementation opinion encourages increased funding support for the BCI industry, including investments from national manufacturing transformation funds and small enterprise development funds [4][5]. - This financial backing is anticipated to accelerate the development of core components and systems in the BCI sector, particularly in key industrialization processes [4][5]. Group 4: Standards and Regulatory Challenges - The sustainable development of the BCI industry relies on the establishment of a comprehensive standard system, including communication protocols for various BCI components [7][8]. - The opinion highlights the need for a data governance framework to protect user information and enhance the security of biological digital information [7][8]. - There are calls for a structured approach to clinical trials and data management to ensure the safety and efficacy of BCI products, particularly in sensitive areas involving brain data [9][10].